,
The two compounds work through entirely independent systems
This guide covers every major GLP-1 drug pipeline candidate worth watching in 2026: the compounds already approved, the assets awaiting regulatory decisions, and the emerging molecules that could define the next decade of metabolic medicine
Preclinical studies have demonstrated that GLP-1 receptor agonists reduce neuroinflammation, reduce tau phosphorylation, reduce amyloid deposition, increase synaptic function, and improve memory formation
However, weight loss itself, whether achieved through medication or lifestyle change, leads to reductions in both fat mass (FM) and lean mass (LM) , meaning that muscle and bone are often lost alongside fat
Nicotinic acid: pharmacological effects and mechanisms of action